ATO and Lena exhibited independent non-interfering effects [67] where ATO sensitized myeloma cells to Lena via the upregulation of cereblon expression, a major target for Lena, resulting in apoptosis [68]. This evidence concerns the gene CRBN and plasma cell myeloma.